Skye Bioscience (SKYE) Net Equity Issued and Repurchased (2013 - 2024)
Skye Bioscience (SKYE) posted quarterly Net Equity Issued and Repurchased of -$83.6 million for Q4 2024, down 1135.81% year-over-year from $8.1 million in Q1 2024, and down 1135.81% quarter-over-quarter from -$6.8 million in Q4 2023.
Skye Bioscience (SKYE) Net Equity Issued and Repurchased (2013 - 2024) Analysis & Trends
Skye Bioscience (SKYE) has reported Net Equity Issued and Repurchased for 6 consecutive years, with -$83.6 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Net Equity Issued and Repurchased fell 1135.81% year-over-year to -$83.6 million; the TTM figure through Dec 2024 stood at -$90.5 million (down 1209.76% YoY), while the FY2023 annual figure was $5.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased slipped to -$83.6 million in Q4 2024 per SKYE's latest filing, from -$6.8 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at -$6.8 million in Q4 2023 and bottomed at -$83.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Skye Bioscience | 10.86 Mn | 10.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -83.56 Mn |
| Dec 31, 2024 | -83.56 Mn |
| Dec 31, 2023 | -6.76 Mn |
| Dec 31, 2023 | -6.76 Mn |
| Dec 31, 2018 | -137,191.00 |
| Dec 31, 2018 | -137,191.00 |
| Jun 30, 2018 | -7,779.00 |
| Jun 30, 2018 | -7,779.00 |
| Mar 31, 2018 | 3.24 Mn |
| Mar 31, 2018 | 3.24 Mn |
| Dec 31, 2015 | -48.00 |
| Dec 31, 2015 | -48.00 |
| Sep 30, 2015 | 7,700.00 |
| Sep 30, 2015 | 7,700.00 |
| Jun 30, 2015 | -7,700.00 |
| Jun 30, 2015 | -7,700.00 |
| Mar 31, 2015 | 721,069.00 |
| Mar 31, 2015 | 721,069.00 |
| Dec 31, 2014 | -4,180.00 |
| Dec 31, 2014 | -4,180.00 |